Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
MindMaze, founded in 2012 and headquartered in Lausanne, Switzerland, is a pioneering company in the field of digital neuro-therapeutics. We specialize in developing medical-grade software, interactive content, and proprietary peripherals designed to restore motor, cognitive, and cardiovascular functions following neural injuries, degeneration, and aging. The company operates within the Internet Software & Services industry, with a focus on healthcare applications.
Since its inception, MindMaze has demonstrated significant growth and attracted substantial investment. The company has raised a total of $348.53 million across various funding rounds, including a Series C round in February 2022 that secured $105 million. Notable investors include AlbaCore Capital, Concord Health Partners, and Salica Investments. MindMaze's innovative approach to brain health and recovery has positioned it as a leader in its field, competing with companies such as Brainomix, ICAROS, and Neuro Rehab VR.
While there is currently no official news regarding MindMaze's IPO prospects, the company's funding history and market position suggest ongoing interest from investors. In November 2023, reports indicated a pending acquisition deal with Genesis Growth Tech Acquisition, valued at $21 million. However, it's important to note that this information is based on reports and has not been officially confirmed by MindMaze.
Factors that could potentially influence any future IPO decision include MindMaze's financial performance, market conditions in the healthcare technology sector, and the company's strategic growth plans. The company's ability to continue innovating in the neuro-therapeutics space and expand its market presence may also play a role in any future capital market decisions.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While MindMaze's IPO prospects remain uncertain, investors eager to explore opportunities in the innovative neurotechnology space don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides the opportunity to invest in potential leaders in cutting-edge industries like neurotechnology, with lower minimum investments than traditional private equity opportunities. This allows you to potentially benefit from MindMaze's growth and innovation before it hits the public markets.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
